Cardiff Oncology (CRDF)
(Real Time Quote from BATS)
$2.48 USD
+0.01 (0.41%)
Updated Oct 2, 2024 09:54 AM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Earnings News For CRDF
-
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q2 Earnings Snapshot
-
Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q1 Earnings Snapshot
-
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates
-
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
-
Cardiff Oncology: Q3 Earnings Snapshot
-
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q2 Earnings Snapshot
-
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
-
Cardiff Oncology: Q1 Earnings Snapshot
-
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
-
Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates
-
Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q3 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q3 Earnings Snapshot
-
Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates
-
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q2 Earnings Snapshot
-
Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates
-
Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?